Literature DB >> 22067635

MRI parameters for prediction of multiple sclerosis diagnosis in children with acute CNS demyelination: a prospective national cohort study.

Leonard H Verhey1, Helen M Branson, Manohar M Shroff, David Ja Callen, John G Sled, Sridar Narayanan, A Dessa Sadovnick, Amit Bar-Or, Douglas L Arnold, Ruth Ann Marrie, Brenda Banwell.   

Abstract

BACKGROUND: Multiple sclerosis (MS) diagnostic criteria incorporate MRI features that can be used to predict later diagnosis of MS in adults with acute CNS demyelination. To identify MRI predictors of a subsequent MS diagnosis in a paediatric population, we created a standardised scoring method and applied it to MRI scans from a national prospective incidence cohort of children with CNS demyelination.
METHODS: Clinical and MRI examinations were done at the onset of acute CNS demyelination and every 3 months in the first year after that, and at the time of a second demyelinating attack. MS was diagnosed on the basis of clinical or MRI evidence of relapsing disease. Baseline MRI scans were assessed for the presence of 14 binary response parameters. Parameters were assessed with a multiple tetrachoric correlation matrix. Univariate analyses and multivariable Cox proportional hazards models were used to identify predictors of MS.
FINDINGS: Between Sept 1, 2004, and June 30, 2010, 332 children and adolescents were assessed for eligibility. 1139 scans were available from 284 eligible participants who had been followed up for 3·9 (SD 1·7) years. 57 (20%) were diagnosed with MS after a median of 188 (IQR 144-337) days. Seven of 14 binary response parameters were retained. The presence of either one or more T1-weighted hypointense lesions (hazard ratio 20·6, 95% CI 5·46-78·0) or one or more periventricular lesions (3·34, 1·27-8·83) was associated with an increased likelihood of MS diagnosis (sensitivity 84%, specificity 93%, positive predictive value 76%, negative predictive value 96%). Risk for MS diagnosis was highest when both parameters were present (34·27, 16·69-70·38). Although the presence of contrast enhancement, cerebral white matter, intracallosal, and brainstem lesions was associated with MS in the univariate analyses, these parameters were not retained in the multivariable models.
INTERPRETATION: Specific MRI parameters can be used to predict diagnosis of MS in children with incident demyelination of the CNS. The ability to promptly identify children with MS will enhance timely access to care and will be important for future clinical trials in paediatric MS. FUNDING: Canadian Multiple Sclerosis Scientific Research Foundation.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 22067635     DOI: 10.1016/S1474-4422(11)70250-2

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  47 in total

1.  Multiple sclerosis: Which MRI findings predict MS development in children?

Authors:  E Ann Yeh
Journal:  Nat Rev Neurol       Date:  2012-02-28       Impact factor: 42.937

2.  [Inflammatory diseases of the central nervous system].

Authors:  Armin Bachhuber
Journal:  Radiologe       Date:  2021-06-08       Impact factor: 0.635

3.  Diffusion tensor MRI as a biomarker in axonal and myelin damage.

Authors:  Wint Yan Aung; Soe Mar; Tammie Ls Benzinger
Journal:  Imaging Med       Date:  2013-10-01

Review 4.  Multiple sclerosis in children: an update on clinical diagnosis, therapeutic strategies, and research.

Authors:  Amy Waldman; Angelo Ghezzi; Amit Bar-Or; Yann Mikaeloff; Marc Tardieu; Brenda Banwell
Journal:  Lancet Neurol       Date:  2014-09       Impact factor: 44.182

5.  Elevated cerebrospinal fluid opening pressure in a pediatric demyelinating disease cohort.

Authors:  Sona Narula; Grant T Liu; Robert A Avery; Brenda Banwell; Amy T Waldman
Journal:  Pediatr Neurol       Date:  2015-01-13       Impact factor: 3.372

6.  Bithalamic Inflammation in Relapsing-Remitting Multiple Sclerosis.

Authors:  Andrew R Romeo; Maulik Shah
Journal:  Neurohospitalist       Date:  2017-01-17

Review 7.  Therapeutic Approach to the Management of Pediatric Demyelinating Disease: Multiple Sclerosis and Acute Disseminated Encephalomyelitis.

Authors:  J Nicholas Brenton; Brenda L Banwell
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

8.  Diagnostic criteria for pediatric multiple sclerosis.

Authors:  Jennifer P Rubin; Nancy L Kuntz
Journal:  Curr Neurol Neurosci Rep       Date:  2013-06       Impact factor: 5.081

9.  Development of a standardized MRI scoring tool for CNS demyelination in children.

Authors:  L H Verhey; H M Branson; S Laughlin; M M Shroff; S M Benseler; B M Feldman; D L Streiner; J G Sled; B Banwell
Journal:  AJNR Am J Neuroradiol       Date:  2013-01-24       Impact factor: 3.825

10.  Clinical and MRI activity as determinants of sample size for pediatric multiple sclerosis trials.

Authors:  Leonard H Verhey; Alessio Signori; Douglas L Arnold; Amit Bar-Or; A Dessa Sadovnick; Ruth Ann Marrie; Brenda Banwell; Maria Pia Sormani
Journal:  Neurology       Date:  2013-08-21       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.